S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Better Than Oil Stocks (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
A collection of the insights Warren Buffett offered in his annual letter Saturday
Better Than Oil Stocks (Ad)
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
Google says its AI image-generator would sometimes 'overcompensate' for diversity
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Better Than Oil Stocks (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
A collection of the insights Warren Buffett offered in his annual letter Saturday
Better Than Oil Stocks (Ad)
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
Google says its AI image-generator would sometimes 'overcompensate' for diversity
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Better Than Oil Stocks (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
A collection of the insights Warren Buffett offered in his annual letter Saturday
Better Than Oil Stocks (Ad)
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
Google says its AI image-generator would sometimes 'overcompensate' for diversity
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Better Than Oil Stocks (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
Better Than Oil Stocks (Ad)
White House, tribal leaders hail 'historic' deal to restore salmon runs in Pacific Northwest
A collection of the insights Warren Buffett offered in his annual letter Saturday
Better Than Oil Stocks (Ad)
MILAN FASHION PHOTOS: Gucci sparkles as De Sarno hits stride
Google says its AI image-generator would sometimes 'overcompensate' for diversity

Scinai Immunotherapeutics (SCNI) Earnings Date, Estimates & Call Transcripts

$0.49
-0.01 (-2.00%)
(As of 02/23/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

SCNI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SCNI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

SCNI Earnings Date and Information

Scinai Immunotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 15th, 2024 based off prior year's report dates.

Scinai Immunotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/15/2024
Estimated)
------- 
10/31/2023Q3 2023-($0.66)($0.66)($0.66)--
8/11/2023Q2 2023-($1.11)($1.11)($1.11)--
5/15/2023Q1 2023-($1.20)($1.20)($1.20)--
4/17/2023Q4 2022-($0.30)($0.30)($0.30)--
11/30/2022Q3 2022($0.10)$0.06+$0.16$0.06--
8/25/2022Q2 2022-($2.10)($2.10)($2.10)--
6/1/2022Q1 2022-($2.00)($2.00)($2.00)--
11/30/2021Q3 2021-($2.00)($2.00)($2.00)--
8/26/2021Q2 2021-($3.70)($3.70)($3.70)--
6/23/2021Q1 2021-($1.90)($1.90)($1.90)--
5/13/2021Q4 2020-($3.60)($3.60)($3.60)--












Scinai Immunotherapeutics Earnings - Frequently Asked Questions

When is Scinai Immunotherapeutics's earnings date?

Scinai Immunotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 15th, 2024 based off last year's report dates. Learn more on SCNI's earnings history.

How much profit does Scinai Immunotherapeutics generate each year?

Scinai Immunotherapeutics (NASDAQ:SCNI) has a recorded net income of -$5.80 million. SCNI has generated -$3.27 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:SCNI) was last updated on 2/24/2024 by MarketBeat.com Staff